A revealing new study once again has confirmed that a natural approach to be far superior to big pharma solutions—this time involving psilocybin, the active compound in magic mushrooms.
The study, published in the scientific journal Neuropharmacology, found that clinically depressed people had increased neural responses to fearful faces one day after a psilocybin-assisted therapy session, which positively predicted positive clinical outcomes.
“Psilocybin-assisted therapy might mitigate depression by increasing emotional connection,” neuroscientist and study author Leor Roseman, a PhD student at Imperial College London, explained to PsyPost.
This is almost the exact opposite of how standard anti-depressants operate, as SSRI’s typically work by creating an “emotional blunting.”
This is unlike SSRI antidepressants which are criticized for creating in many people a general emotional blunting,” noted Roseman.
Source: News To Me